Accelerated Approval Drug Promotions Run Risk Of Overstating Efficacy, Understating Safety

 
• By Sue Sutter
  
Skunk
By promoting data from a confirmatory trial that was not conducted with due diligence, are sponsors poking the skunk of a new prohibited act under the FDCA? • Source: Shutterstock

More from Marketing & Advertising

More from Compliance